C330006K01Rik Activators
Ap5z1, a subunit of the AP-5 adaptor complex, emerges as a multifaceted protein involved in cellular processes crucial for maintaining genomic integrity and intracellular transport. Predicted functions include participation in double-strand break repair via homologous recombination and endosomal transport, positioning Ap5z1 at the crossroads of DNA repair and protein transport pathways. Activation of Ap5z1 involves both direct and indirect mechanisms orchestrated by various chemical compounds. Etoposide and camptothecin directly activate Ap5z1 by inducing DNA damage, fostering homologous recombination for repair, and emphasizing its role in safeguarding genomic stability. Indirect activators include agents like bafilomycin A1 and nocodazole, which impact endosomal transport and cytoskeletal dynamics, respectively, contributing to Ap5z1-mediated functions in protein transport and cellular organization. Wortmannin and A23187 indirectly activate Ap5z1 by perturbing PI3K-dependent and calcium-dependent pathways, respectively, influencing DNA repair and endosomal transport processes.
Furthermore, the impact of MG-132 on protein transport and N-acetyl cysteine (NAC) in mitigating oxidative stress highlights Ap5z1's activation in response to cellular stressors. Lys05 indirectly activates Ap5z1 through lysosomal deacidification, influencing endosomal transport. Cisplatin induces DNA damage, while chloroquine, an autophagy inhibitor, and caffeine, an ATM kinase inhibitor, indirectly impact Ap5z1 by affecting endosomal transport and DNA repair processes, respectively. In essence, Ap5z1 activation is intricately connected to its functions in DNA repair and endosomal transport, responding to both direct DNA damage-inducing agents and indirect modulators of cellular processes. The interplay of these chemical compounds unveils the dynamic regulatory landscape governing Ap5z1, positioning it as a pivotal player in maintaining genomic stability and intracellular transport mechanisms. Future investigations into the specific nuances of Ap5z1 activation promise to unravel new dimensions of its role in cellular homeostasis and disease processes related to hereditary spastic paraplegia and other conditions associated with its dysregulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide, a topoisomerase II inhibitor, directly activates Ap5z1 by inducing double-strand breaks, triggering homologous recombination for repair. The drug facilitates Ap5z1 involvement in DNA repair processes, aligning with its predicted function in double-strand break repair via homologous recombination. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1, a V-ATPase inhibitor, indirectly activates Ap5z1 by impacting endosomal transport. Inhibition of V-ATPase alters the pH within endosomes, influencing their dynamics and consequently modulating Ap5z1's role in endosomal transport. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole, a microtubule destabilizer, indirectly activates Ap5z1 by disrupting the cytoskeletal network. The destabilization of microtubules alters cellular organization, impacting Ap5z1's localization in the cytoplasm and nuclear speck. This indirectly influences its participation in DNA repair and protein transport processes predicted for Ap5z1. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187, a calcium ionophore, indirectly activates Ap5z1 by influencing calcium-dependent processes. The ionophore impacts calcium signaling, potentially influencing Ap5z1-mediated functions associated with endosomal transport or double-strand break repair via homologous recombination. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
N-Acetyl-L-cysteine (NAC), an antioxidant, indirectly activates Ap5z1 by mitigating oxidative stress. Oxidative stress affects cellular processes, and NAC's antioxidant properties may contribute to Ap5z1 activation in response to DNA damage, aligning with its predicted role in double-strand break repair via homologous recombination. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin, a topoisomerase I inhibitor, directly activates Ap5z1 by inducing DNA damage and promoting homologous recombination for repair. The drug's impact on topoisomerase I aligns with Ap5z1's predicted function in double-strand break repair via homologous recombination. | ||||||
Lys05 | 1391426-24-6 | sc-507532 | 5 mg | $140.00 | ||
Lys05, a lysosomal deacidification agent, indirectly activates Ap5z1 by influencing lysosomal function. The agent alters lysosomal pH, potentially impacting Ap5z1-mediated endosomal transport processes, in line with its predicted involvement. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin, a DNA-damaging agent, directly activates Ap5z1 by inducing double-strand breaks and promoting homologous recombination for repair. The drug's impact on DNA aligns with Ap5z1's predicted function in double-strand break repair via homologous recombination. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine, an autophagy inhibitor, indirectly activates Ap5z1 by influencing endosomal transport. Inhibition of autophagy impacts cellular processes, potentially modulating Ap5z1's role in endosomal transport as predicted. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine, an ATM kinase inhibitor, indirectly activates Ap5z1 by influencing DNA repair processes. Inhibition of ATM kinase affects the DNA damage response, potentially impacting Ap5z1-mediated double-strand break repair via homologous recombination, aligning with its predicted function. | ||||||